Cargando…

Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that presents a great challenge for treatment and prevention.. This study aims to implement a machine learning approach that employs such datasets to identify potential biomarker targets. We developed a pipeline to identify potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafiha, Roshan, Bahcivanci, Basak, Gkoutos, Georgios V., Acharjee, Animesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615894/ https://www.ncbi.nlm.nih.gov/pubmed/34829865 http://dx.doi.org/10.3390/biomedicines9111636

Ejemplares similares

Associating transcriptomics data with inflammatory markers to understand tumour microenvironment in hepatocellular carcinoma
por: Bahcivanci, Basak, et al.
Publicado: (2022)

Role of microbiota and microbiota‐derived short‐chain fatty acids in PDAC
por: Temel, Hülya Yılmaz, et al.
Publicado: (2022)

Machine Learning-Based Identification of Colon Cancer Candidate Diagnostics Genes
por: Koppad, Saraswati, et al.
Publicado: (2022)

-Omics biomarker identification pipeline for translational medicine
por: Bravo-Merodio, Laura, et al.
Publicado: (2019)

NFnetFu: A novel workflow for microbiome data fusion
por: Bisht, Vartika, et al.
Publicado: (2021)

Machine learning for the detection of early immunological markers as predictors of multi-organ dysfunction
por: Bravo-Merodio, Laura, et al.
Publicado: (2019)

A random forest based biomarker discovery and power analysis framework for diagnostics research
por: Acharjee, Animesh, et al.
Publicado: (2020)

CACONET: a novel classification framework for microbial correlation networks
por: Xu, Yuanwei, et al.
Publicado: (2022)

Editorial: Integrative multi-modal, multi-omics analytics for the better understanding of metabolic diseases
por: Acharjee, Animesh, et al.
Publicado: (2023)

Biomarker Prioritisation and Power Estimation Using Ensemble Gene Regulatory Network Inference
por: Aziz, Furqan, et al.
Publicado: (2020)

Cloud Computing Enabled Big Multi-Omics Data Analytics
por: Koppad, Saraswati, et al.
Publicado: (2021)

Link prediction in complex network using information flow
por: Aziz, Furqan, et al.
Publicado: (2023)

Machine learning based attribution mapping of climate related discussions on social media
por: Kaushal, Akshay, et al.
Publicado: (2022)

Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer
por: Bisht, Vartika, et al.
Publicado: (2021)

Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning
por: Cao, Yang, et al.
Publicado: (2023)

Identification of biomarkers in nonalcoholic fatty liver disease: A machine learning method and experimental study
por: Han, Na, et al.
Publicado: (2022)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
por: Ghandian, Sina, et al.
Publicado: (2022)

Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease
por: Nazari, Elham, et al.
Publicado: (2023)

Integration of metabolomics, lipidomics and clinical data using a machine learning method
por: Acharjee, Animesh, et al.
Publicado: (2016)

Identification of potential biomarkers of myopia based on machine learning algorithms
por: Zhang, Shengnan, et al.
Publicado: (2023)

Multimorbidity prediction using link prediction
por: Aziz, Furqan, et al.
Publicado: (2021)

Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models
por: Russ, Dominic, et al.
Publicado: (2022)

A Causal Web between Chronotype and Metabolic Health Traits
por: Williams, John A., et al.
Publicado: (2021)

Correction: Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models
por: Russ, Dominic, et al.
Publicado: (2023)

Novel potential biomarkers for severe alcoholic liver disease
por: Huang, Jia, et al.
Publicado: (2022)

Glutamate–Serine–Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease
por: Leonetti, Simone, et al.
Publicado: (2020)

Comparison of Machine Learning Models and the Fatty Liver Index in Predicting Lean Fatty Liver
por: Su, Pei-Yuan, et al.
Publicado: (2023)

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
por: Hardy, Timothy, et al.
Publicado: (2017)

Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Afonso, Marta B., et al.
Publicado: (2016)

Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes
por: Tsamos, Georgios, et al.
Publicado: (2023)

Machine learning for high-throughput field phenotyping and image processing provides insight into the association of above and below-ground traits in cassava (Manihot esculenta Crantz)
por: Selvaraj, Michael Gomez, et al.
Publicado: (2020)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression
por: Perveen, Sajida, et al.
Publicado: (2018)

Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices
por: Razmpour, Farkhondeh, et al.
Publicado: (2023)

S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
por: Liu, Xiaolin, et al.
Publicado: (2015)

Fatty liver biomarkers and insulin resistance indices in the prediction of non‐alcoholic fatty liver disease in Ghanaian patients
por: Bockarie, A. S., et al.
Publicado: (2023)

Advancing proteomics and machine learning in the clinic: an editorial on “Noninvasive proteomic biomarkers for alcohol-related liver disease”
por: McGinnis, Courtney D., et al.
Publicado: (2022)

Identification of early liver toxicity gene biomarkers using comparative supervised machine learning
por: Smith, Brandi Patrice, et al.
Publicado: (2020)

Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning
por: Wang, Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nq12lm36g3nd20092a7cgc7cfv